1 authorised product containing COVID-19 mRNA vaccine (nucleoside-modified), from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| COMIRNATY KP.2 30 micrograms/dose dispersion for injection adults and adolescents from 12 year EU/1/20/1528/037-038 |
COVID-19 mRNA vaccine (nucleoside-modified) | BioNTech Manufacturing GmbH | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 7 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.